Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Theriva Biologics (NYSE American:TOVX) Reports Lower Research Spending and USD 8.5 Million in Cash

The filing describes the enzyme as intended to break down the tumor stroma barrier surrounding the tumor. VCN-01 has been evaluated in the Phase 2b VIRAGE study in pancreatic cancer, a Phase 1 study in retinoblastoma and other Phase 1 studies in solid tumors, …

Nitish Kishor | 13 November 2026

Trio-Tech International (NASDAQ:TRT) Reports First-Quarter Fiscal 2027 Revenue Up 28.6% to USD 19.9 Million

The filing states that total revenue increased by USD 4,435 thousand, or 28.6%, to USD 19,949 thousand in the first quarter of fiscal 2027.

Nitish Kishor | 13 November 2026

Taysha Gene Therapies (NASDAQ:TSHA) Reports All 33 TSHA-102 Patients Through Acute Safety Window

Management said that, following completion of dosing in both the REVEAL pivotal and ASPIRE trials, all 33 patients dosed with TSHA-102 have cleared the acute post-dosing safety monitoring period associated with AAV gene therapies. Of these, 29 were dosed in the REVEAL Phase 1/2 …

Nitish Kishor | 13 November 2026

Twist Bioscience (NASDAQ:TWST) Posts Positive Adjusted EBITDA in Fiscal Fourth Quarter and Guides to USD 550 Million in Fiscal 2027 Revenue

DNA Synthesis and Protein Solutions revenue grew 33% to USD 61.0 million, against USD 46.0 million, and grew 8% sequentially from USD 56.6 million. NGS Applications revenue grew 24% to USD 65.7 million, against USD 53.0 million, and grew 6% sequentially from USD 61.8 …

Nitish Kishor | 13 November 2026

United States Antimony (NYSE:UAMY) Reports Third-Quarter Revenue of USD 10.1 Million With Gross Margin of 42% and New Volume Guidance

Chief Financial Officer Shawn Winkler said revenue was up 16% year over year and 28% from the second quarter, withGross Profitmore than doubling.

Nitish Kishor | 13 November 2026

INNOVATE Corp. (NYSE:VATE) Reports Third-Quarter Revenue of USD 495.5 Million and Net Income of USD 28.3 Million After DBMG Sale

TheQuarterly Reportdescribes two substantial asset dispositions: the sale of a controlling interest in Spectrum, completed on September 1, 2026, and the sale of DBM Global, or DBMG, which closed on October 5, 2026, after the quarter end. The company states that these actions substantially …

Nitish Kishor | 13 November 2026

Vista Gold (NYSE American:VGZ) Reports Third-Quarter Loss and Updates Proposed Artemis Gold Transaction

Vista is a development-stage gold company. Its flagship asset is the Mt Todd Gold Project in the Northern Territory of Australia, which the company describes as having a large gold reserve, development optionality, expansion opportunities and exploration upside.

Nitish Kishor | 13 November 2026

VolitionRx (NYSE American:VNRX) Reports Third-Quarter Revenue of USD 1.6 Million and Narrower Net Loss

Product revenue was USD 1,613,876, against USD 538,381, and the company recorded no services revenue, against USD 88,896. Total revenues were USD 1,613,876, against USD 627,277.

Nitish Kishor | 13 November 2026

Verrica Pharmaceuticals (NASDAQ:VRCA) Reports Third-Quarter Revenue of USD 6.9 Million as YCANTH Product Sales Rise

YCANTH net product revenue was USD 5.7 million, against USD 3.6 million in the third quarter of 2025, and the company reported it as up 11.9% over the previous quarter and 57.9% year over year. The company linked the increase primarily to higher deliveries …

Nitish Kishor | 13 November 2026

VirTra (NASDAQ:VTSI) Reports Third-Quarter Revenue of USD 7.6 Million, Net Income of USD 2.2 Million and Backlog of USD 27.6 Million

Chief Financial Officer Alanna Boudreau said revenue rose from USD 5.8 million in the second quarter and USD 3.5 million in the first quarter, reflecting improved revenue conversion and international deliveries. Government revenue was USD 5.0 million, against USD 4.1 million, and international revenue …

Nitish Kishor | 13 November 2026
Support

Hi! How can we help you today?

Loading…